Patents by Inventor Steven Dworetzky

Steven Dworetzky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO ELEVATED LEVELS OF EOSINOPHILS AND/OR BASOPHILS
    Publication number: 20230277509
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of eosinophils and/or basophils, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Application
    Filed: March 6, 2023
    Publication date: September 7, 2023
    Inventors: Michael E. BOZIK, Gregory HEBRANK, Wildon FARWELL, Thomas PETZINGER, Jr., Steven DWORETZKY
  • Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
    Patent number: 11612589
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of eosinophils and/or basophils, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Grant
    Filed: November 18, 2020
    Date of Patent: March 28, 2023
    Assignee: Areteia Therapeutics, Inc.
    Inventors: Michael E. Bozik, Gregory Hebrank, Wildon Farwell, Thomas Petzinger, Jr., Steven Dworetzky
  • METHODS OF USE FOR KV7 CHANNEL ACTIVATORS
    Publication number: 20220323417
    Abstract: Provided herein are compounds and pharmaceutical compositions comprising a therapeutically effective amount of such compounds, or pharmaceutically acceptable salts, and a pharmaceutically acceptable excipient, and methods of treating neurodevelopmental diseases or disorders (NDD) and developmental and epileptic encephalopathy (DEE), comprising administering such compounds, or pharmaceutically acceptable salts, and pharmaceutical compositions, to pediatric patients.
    Type: Application
    Filed: September 17, 2020
    Publication date: October 13, 2022
    Applicant: Knopp Biosciences LLC
    Inventors: Michael E. BOZIK, Steven DWORETZKY, Kelly PICCHIONE, Gregory HEBRANK, Thomas PETZINGER, Jr.
  • COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO ELEVATED LEVELS OF EOSINOPHILS AND/OR BASOPHILS
    Publication number: 20210267949
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of eosinophils and/or basophils, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Application
    Filed: November 18, 2020
    Publication date: September 2, 2021
    Inventors: Michael E. BOZIK, Gregory HEBRANK, Wildon FARWELL, Thomas PETZINGER, JR., Steven DWORETZKY
  • Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
    Patent number: 11026928
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of eosinophils and/or basophils, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: June 8, 2021
    Assignee: Knopp Biosciences LLC
    Inventors: Michael E. Bozik, Gregory Hebrank, Wildon Farwell, Thomas Petzinger, Jr., Steven Dworetzky
  • Compositions and methods for treating conditions related to increased eosinophils
    Patent number: 10980783
    Abstract: Disclosed herein are methods of treating diseases associated with increased numbers of eosinophils basophils, and/or neutrophils with R(+) pramipexole.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: April 20, 2021
    Assignee: KNOPP BIOSCIENCES LLC
    Inventors: Michael E. Bozik, Gregory Hebrank, Wildon Farwell, Thomas Petzinger, Jr., Steven Dworetzky
  • Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
    Patent number: 10828284
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of eosinophils and/or basophils, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Grant
    Filed: July 11, 2014
    Date of Patent: November 10, 2020
    Assignee: Knopp Biosciences LLC
    Inventors: Michael E. Bozik, Gregory Hebrank, Thomas Petzinger, Jr., Steven Dworetzky, Wildon Farwell
  • Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
    Patent number: 10456381
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of plasma cells and/or B-cells, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: October 29, 2019
    Assignee: Knopp Biosciences LLC
    Inventors: Michael E. Bozik, Steven Dworetzky
  • COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO INCREASED EOSINOPHILS
    Publication number: 20190321339
    Abstract: Disclosed herein are methods of treating diseases associated with increased numbers of eosinophils basophils, and/or neutrophils with R(+) pramipexole.
    Type: Application
    Filed: July 2, 2019
    Publication date: October 24, 2019
    Inventors: Michael E. BOZIK, Gregory HEBRANK, Wildon FARWELL, Thomas PETZINGER, JR., Steven DWORETZKY
  • Compositions and methods for treating conditions related to increased eosinophils
    Patent number: 10383856
    Abstract: Disclosed herein are methods of treating diseases associated with increased numbers of eosinophils basophils, and/or neutrophils with R(+) pramipexole.
    Type: Grant
    Filed: June 14, 2016
    Date of Patent: August 20, 2019
    Assignee: Knopp Biosciences LLC
    Inventors: Michael E. Bozik, Gregory Hebrank, Wildon Farwell, Thomas Petzinger, Jr., Steven Dworetzky
  • Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
    Patent number: 10383857
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of eosinophils and/or basophils, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: August 20, 2019
    Assignee: Knopp Biosciences LLC
    Inventors: Michael E. Bozik, Gregory Hebrank, Thomas Petzinger, Jr., Steven Dworetzky, Wildon Farwell
  • Compositions and methods for treating chronic urticaria
    Patent number: 10195183
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of mast cells, basophils, eosinophils, or a combination thereof, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: February 5, 2019
    Assignee: Knopp Biosciences LLC
    Inventors: Michael E Bozik, Steven Dworetzky
  • COMPOSITIONS AND METHODS FOR TREATING PLASMA CELL DISORDERS AND B-CELL PROLYMPHOCYTIC DISORDERS
    Publication number: 20190022070
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of plasma cells and/or B-cells, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Application
    Filed: June 20, 2018
    Publication date: January 24, 2019
    Inventors: Michael E. BOZIK, Steven DWORETZKY
  • COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO ELEVATED LEVELS OF EOSINOPHILS AND/OR BASOPHILS
    Publication number: 20180271839
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of eosinophils and/or basophils, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Application
    Filed: March 16, 2018
    Publication date: September 27, 2018
    Inventors: Michael E. BOZIK, Gregory HEBRANK, Wildon FARWELL, Thomas PETZINGER, Steven DWORETZKY
  • COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO ELEVATED LEVELS OF EOSINOPHILS AND/OR BASOPHILS
    Publication number: 20180228777
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of eosinophils and/or basophils, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Application
    Filed: February 6, 2018
    Publication date: August 16, 2018
    Inventors: Michael E. BOZIK, Gregory HEBRANK, Thomas PETZINGER, JR., Steven DWORETZKY, Wildon FARWELL
  • Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
    Patent number: 10028940
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of plasma cells and/or B-cells, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Grant
    Filed: March 16, 2017
    Date of Patent: July 24, 2018
    Assignee: Knopp Biosciences LLC
    Inventors: Michael E. Bozik, Steven Dworetzky
  • COMPOSITIONS AND METHODS FOR TREATING CHRONIC URTICARIA
    Publication number: 20180015073
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of mast cells, basophils, eosinophils, or a combination thereof, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Application
    Filed: August 14, 2017
    Publication date: January 18, 2018
    Inventors: Michael E. BOZIK, Steven DWORETZKY
  • COMPOSITIONS AND METHODS FOR TREATING PLASMA CELL DISORDERS AND B-CELL PROLYMPHOCYTIC DISORDERS
    Publication number: 20170281604
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of plasma cells and/or B-cells, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Application
    Filed: March 16, 2017
    Publication date: October 5, 2017
    Inventors: Michael E. BOZIK, Steven DWORETZKY
  • Compositions and methods for treating chronic urticaria
    Patent number: 9763918
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of mast cells, basophils, eosinophils, or a combination thereof, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Grant
    Filed: August 13, 2014
    Date of Patent: September 19, 2017
    Assignee: Knopp Biosciences LLC
    Inventors: Michael E. Bozik, Steven Dworetzky
  • Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
    Patent number: 9642840
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of plasma cells and/or B-cells, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Grant
    Filed: August 13, 2014
    Date of Patent: May 9, 2017
    Assignee: Knopp Biosciences, LLC
    Inventors: Michael E. Bozik, Steven Dworetzky